WS #13331
Holding: newest synthesis is 110d 6h old
Investors react negatively to potential $400B AZN-BMY merger, with AZN down 8%.
AstraZeneca-Bristol Myers merger rejected by investors
Investors react negatively to potential $400B AZN-BMY merger, with AZN down 8%.